Novitium Pharma LLC recalls Digoxin Tablets
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- Hazard
- Failed Impurities/Degradation Specifications
- Products
-
- Digoxin Tablets
- Company
- Novitium Pharma LLC
- Where it was sold
-
U.S. Nationwide
Nationwide
- Units affected
- 1,003 bottles
- About this recall
- Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-200-10